Tight relationships between B lymphocytes and the skeletal system

被引:60
作者
Manilay, Jennifer O. [1 ,2 ]
Zouali, Moncef [3 ,4 ]
机构
[1] Univ Calif Merced, Sch Nat Sci, Mol & Cell Biol Unit, Merced, CA 95343 USA
[2] Univ Calif Merced, Sch Nat Sci, Quantitat & Syst Biol Grad Grp, Merced, CA 95343 USA
[3] INSERM, UMR S 606 1132, F-75475 Paris, France
[4] Univ Paris Diderot, Sorbonne Paris Cite, F-75475 Paris, France
关键词
osteoimmunology; B lymphocyte; osteoclast; osteoblast; osteocyte; MESENCHYMAL STEM-CELLS; NF-KAPPA-B; BONE-MARROW; CRE RECOMBINASE; TRANSGENIC MICE; OSTEOCLAST DIFFERENTIATION; OSTEOPROTEGERIN; EXPRESSION; LYMPHOPOIESIS; REGULATOR;
D O I
10.1016/j.molmed.2014.03.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Mounting evidence indicates that the immune system and the skeletal system share several regulatory nodes. B lymphocytes, which play key roles in immune homeostasis, are uniquely endowed with osteointeractive properties. From their early development to the plasma cell stage, they are in close proximity with the skeletal system and produce factors important for bone maintenance. Not surprisingly, perturbation of B lymphopoiesis affects bone mass. Reciprocally, inactivation of bone cell functions results in B cell development blocks. This new understanding is refining our insights into the pathogenesis of several diseases such as periodontitis and rheumatoid arthritis.
引用
收藏
页码:405 / 412
页数:8
相关论文
共 84 条
[1]
B cells produce pathogenic antibodies and impair recovery after spinal cord injury in mice [J].
Ankeny, Daniel P. ;
Guan, Zhen ;
Popovich, Phillip G. .
JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (10) :2990-2999
[2]
Mesenchymal stem cells suppress B-cell terminal differentiation [J].
Asari, Sadaki ;
Itakura, Shin ;
Ferreri, Kevin ;
Liu, Chih-Pin ;
Kuroda, Yoshikazu ;
Kandeel, Fouad ;
Mullen, Yoko .
EXPERIMENTAL HEMATOLOGY, 2009, 37 (05) :604-615
[3]
Hematological defects in the oc/oc mouse, a model of infantile malignant osteopetrosis [J].
Blin-Wakkach, C ;
Wakkach, A ;
Sexton, PM ;
Rochet, N ;
Carle, GF .
LEUKEMIA, 2004, 18 (09) :1505-1511
[4]
Regulation of osteoprotegerin mRNA levels by prostaglandin E2 in human bone marrow stroma cells [J].
Brändström, H ;
Jonsson, KB ;
Ohlsson, C ;
Vidal, O ;
Ljunghall, S ;
Ljunggren, Ö .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 247 (02) :338-341
[5]
New therapies in the management of rheumatoid arthritis [J].
Buch, Maya H. ;
Emery, Paul .
CURRENT OPINION IN RHEUMATOLOGY, 2011, 23 (03) :245-251
[6]
The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts [J].
Burgess, TL ;
Qian, YX ;
Kaufman, S ;
Ring, BD ;
Van, G ;
Capparelli, C ;
Kelley, M ;
Hsu, HL ;
Boyle, WJ ;
Dunstan, CR ;
Hu, S ;
Lacey, DL .
JOURNAL OF CELL BIOLOGY, 1999, 145 (03) :527-538
[7]
Absence of sclerostin adversely affects B-cell survival [J].
Cain, Corey J. ;
Rueda, Randell ;
McLelland, Bryce ;
Collette, Nicole M. ;
Loots, Gabriela G. ;
Manilay, Jennifer O. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (07) :1451-1461
[8]
Transgenic mice that express Cre recombinase in osteoclasts [J].
Chiu, WSM ;
McManus, JF ;
Notini, AJ ;
Cassady, AI ;
Zajac, JD ;
Davey, RA .
GENESIS, 2004, 39 (03) :178-185
[9]
B cells activated in the presence of Th1 cytokines inhibit osteoclastogenesis [J].
Choi, Y ;
Kim, JJ .
EXPERIMENTAL AND MOLECULAR MEDICINE, 2003, 35 (05) :385-392
[10]
Choi Y, 2001, EUR J IMMUNOL, V31, P2179, DOI 10.1002/1521-4141(200107)31:7<2179::AID-IMMU2179>3.0.CO